Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
4,396
Frequently Asked Questions
What is Market Cap of Integra Lifesciences Holdings Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Integra Lifesciences Holdings Corp market cap is $1.15B.
What is the 52-week high for Integra Lifesciences Holdings Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Integra Lifesciences Holdings Corp 52 week high is $27.13 as of September 19, 2025.
What is the 52-week low for Integra Lifesciences Holdings Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Integra Lifesciences Holdings Corp 52 week low is $11.06 as of September 19, 2025.
What is Integra Lifesciences Holdings Corp stock price today?
Integra Lifesciences Holdings Corp stock price today is $15.38.
What was Integra Lifesciences Holdings Corp stock price yesterday?
Integra Lifesciences Holdings Corp stock price yesterday was $14.80.
What is the PE ratio of Integra Lifesciences Holdings Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Integra Lifesciences Holdings Corp’s P/E ratio is -2.27.
What is the Price-to-Book ratio of Integra Lifesciences Holdings Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Integra Lifesciences Holdings Corp P/B ratio is 1.1103.
What is the 50-day moving average of Integra Lifesciences Holdings Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Integra Lifesciences Holdings Corp 50-day moving average is $13.69.
How many employess does Integra Lifesciences Holdings Corp has?
Integra Lifesciences Holdings Corp has 4,396 employees.
